Biosimilars and Biologics: Implementation and Monitoring in a Healthcare Setting

Among the most anticipated and discussed segments of the pharmaceutical market, biosimilars, are finally beginning to exert a greater impact on practice. To meet the growing need for information, ASHP has published Biosimilars and Biologics. This authoritative, evidence-based resource provides an in-depth perspective on all areas related to these innovative drugs, including:: · Legislative/regulatory issues, including the biosimilars act and anticipated FDA guidelines · The safety, efficacy, and interchangeability of biologics · The science and analytical chemistry associated with the manufacture of biologics · Needed pharmacovigilance and adverse effect reporting systems · Formulary management